Evidence map›Paper›PMID 26106036›Full record

ArticleNature communications2015

Haploinsufficiency for BRCA1 leads to cell-type-specific genomic instability and premature senescence.

Maja Sedic, Adam Skibinski, Nelson Brown, Mercedes Gallardo, Peter Mulligan, Paula Martinez, Patricia J Keller, Eugene Glover, Andrea L Richardson, Janet Cowan and 8 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 91 papers.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed
9.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

91 citing papers in PubMed, 138 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Observational
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Cells-of-Origin of Breast Cancer and Intertumoral Heterogeneity.Advances in experimental medicine and biology · 2025
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. A Molecular Characterization of the Allelic Expression of theInternational journal of molecular sciences · 2024
    Article
  20. Article

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 8 institutions in 2 countries.

Maja Sedic1] Program in Cell, Molecular and Developmental Biology, Sackler School of Graduate Biomedical Sciences, Tufts University School of Medicine, 136 Harrison Avenue, Boston, Massachusetts 02111, USA [2] Molecular Oncology Research Institute, Tufts Medical Center, 800 Washington Street, Boston, Massachusetts 02111, USA.
Adam Skibinski1] Program in Cell, Molecular and Developmental Biology, Sackler School of Graduate Biomedical Sciences, Tufts University School of Medicine, 136 Harrison Avenue, Boston, Massachusetts 02111, USA [2] Molecular Oncology Research Institute, Tufts Medical Center, 800 Washington Street, Boston, Massachusetts 02111, USA.
Nelson BrownMolecular Oncology Research Institute, Tufts Medical Center, 800 Washington Street, Boston, Massachusetts 02111, USA.
Mercedes GallardoTelomeres and Telomerase Group, Spanish National Cancer Centre, Madrid E-28029, Spain.
Peter MulliganDepartment of Cell Biology, Harvard Medical School and Massachusetts General Hospital Cancer Center, Building 149, 13th Street, Charlestown, Massachusetts 02129, USA.
Paula MartinezTelomeres and Telomerase Group, Spanish National Cancer Centre, Madrid E-28029, Spain.
Patricia J KellerMolecular Oncology Research Institute, Tufts Medical Center, 800 Washington Street, Boston, Massachusetts 02111, USA.
Eugene Glover1] Program in Cell, Molecular and Developmental Biology, Sackler School of Graduate Biomedical Sciences, Tufts University School of Medicine, 136 Harrison Avenue, Boston, Massachusetts 02111, USA [2] Molecular Oncology Research Institute, Tufts Medical Center, 800 Washington Street, Boston, Massachusetts 02111, USA.
Andrea L RichardsonDepartment of Pathology, Harvard Medical School, Brigham and Women's Hospital, 75 Francis Street, Boston, Massachusetts 02115, USA.
Janet CowanDepartment of Pathology, Tufts Medical Center, 800 Washington Street, Boston, Massachusetts 02111, USA.
Amanda E TolandDepartment of Molecular Virology, Immunology, and Medical Genetics, Department of Internal Medicine's Division of Human Genetics, Ohio State University, Columbus, Ohio 43210, USA.
Krithika RavichandranMolecular and Cellular Oncogenesis Program, The Wistar Institute, 36th and Spruce Sts. Philadelphia, Pennsylvania 19104, USA.
Harold RiethmanMolecular and Cellular Oncogenesis Program, The Wistar Institute, 36th and Spruce Sts. Philadelphia, Pennsylvania 19104, USA.
Stephen P NaberDepartment of Pathology, Tufts Medical Center, 800 Washington Street, Boston, Massachusetts 02111, USA.
Anders M NäärDepartment of Cell Biology, Harvard Medical School and Massachusetts General Hospital Cancer Center, Building 149, 13th Street, Charlestown, Massachusetts 02129, USA.
Maria A BlascoTelomeres and Telomerase Group, Spanish National Cancer Centre, Madrid E-28029, Spain.
Philip W HindsMolecular Oncology Research Institute, Tufts Medical Center, 800 Washington Street, Boston, Massachusetts 02111, USA.
Charlotte Kuperwasser1] Program in Cell, Molecular and Developmental Biology, Sackler School of Graduate Biomedical Sciences, Tufts University School of Medicine, 136 Harrison Avenue, Boston, Massachusetts 02111, USA [2] Molecular Oncology Research Institute, Tufts Medical Center, 800 Washington Street, Boston, Massachusetts 02111, USA.
Tufts Medical Center · USSpanish National Cancer Research Centre · ESHarvard University · USMolecular Oncology (United States) · USThe Wistar Institute · USTufts University · USMassachusetts General Hospital · USThe Ohio State University · US

Funding

Tumor Microenvironment and MetastasisP30CA010815 · NCI · WISTAR INSTITUTE · PI Luis J Montaner · 1985 to 2026
$75.9M
The Role of PlGF in Normal and Neoplastic AngiogenesisP01CA092644 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI DVORAK, HAROLD FISHER · 2002 to 2013
$17.2M
Mechanisms of estrogen action on bone marrow-derived stem stromal cellsR01CA125554 · NCI · TUFTS UNIVERSITY BOSTON · PI KUPERWASSER, CHARLOTTE · 2007 to 2011
$1.5M
A novel single-molecule telomere characterization technology for analyzing cancerR21CA177395 · NCI · WISTAR INSTITUTE · PI RIETHMAN, HAROLD, XIAO, MING · 2014 to 2016
$727k
Nanomapping-Assisted Analysis of Human Telomere RegionsR21HG007205 · NHGRI · WISTAR INSTITUTE · PI RIETHMAN, HAROLD, XIAO, MING · 2013 to 2014
$467k
NCI NIH HHS CA092644NCI NIH HHS CA125554NCI NIH HHS P01 CA092644NCI NIH HHS P30 CA010815NCI NIH HHS R01 CA125554NCI NIH HHS R21 CA177395NHGRI NIH HHS R21 HG007205
6 · The paper itself

Abstract

Although BRCA1 function is essential for maintaining genomic integrity in all cell types, it is unclear why increased risk of cancer in individuals harbouring deleterious mutations in BRCA1 is restricted to only a select few tissues. Here we show that human mammary epithelial cells (HMECs) from BRCA1-mutation carriers (BRCA1(mut/+)) exhibit increased genomic instability and rapid telomere erosion in the absence of tumour-suppressor loss. Furthermore, we uncover a novel form of haploinsufficiency-induced senescence (HIS) specific to epithelial cells, which is triggered by pRb pathway activation rather than p53 induction. HIS and telomere erosion in HMECs correlate with misregulation of SIRT1 leading to increased levels of acetylated pRb as well as acetylated H4K16 both globally and at telomeric regions. These results identify a novel form of cellular senescence and provide a potential molecular basis for the rapid cell- and tissue- specific predisposition of breast cancer development associated with BRCA1 haploinsufficiency.

Indexed as

Genes, BRCA1HaploinsufficiencyCellular SenescenceDNA DamageEpithelial CellsGenomic InstabilityHeterozygoteHumansMammary Glands, HumanMutationRetinoblastoma ProteinSirtuin 1Telomere ShorteningTumor Suppressor Protein p53Retinoblastoma ProteinSIRT1 protein, humanSirtuin 1TP53 protein, humanTumor Suppressor Protein p53

Identifiers

PMID26106036
PMCPMC4491827
OpenAlexW2097432110

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.